-
Inhibitory roles of protein kinase B and peroxisome proliferator-activated receptor gamma coactivator on hepatic HMG-CoA reductase promoter activity
Gene C. Ness, Jeffrey L. Edelman
Advances in Bioscience and Biotechnology
Vol.4 No.10B,
September
12,
2013
DOI:
10.4236/abb.2013.410A3001
-
The C161T Polymorphism in Peroxisome Proliferator-Activated Receptor ɣ2, but Not Pro12Ala, Is Associated with Diabetic Retinopathy in Type 2 Diabetes Mellitus in an Egyptian Population
Ragaa Abelkader Ramadan, Moyassar Ahmad Zaki, Rania Mohamed El Sharkawy, Lubna Mohamed Desouky, Marwa Ahmed Madkour, Karim Mahmoud Nabil Mohamed Kamel
Journal of Diabetes Mellitus
Vol.6 No.1,
December
25,
2015
DOI:
10.4236/jdm.2016.61001
-
Activation of peroxisome proliferator activated receptor-gamma results in an atheroprotective apolipoprotein profile in HepG2 cells
Diala F. Dahabreh, Jheem D. Medh
Advances in Biological Chemistry
Vol.2 No.3,
August
22,
2012
DOI:
10.4236/abc.2012.23026
-
Differential Mechanisms of the Effect of Peroxisome Proliferator-Activated Receptor Gamma Agonists on Bleomycin-Induced Lung Fibrosis
Keisuke Miyamoto, Sadatomo Tasaka, Yasushi Nakano, Hiromi Shinoda, Hirofumi Kamata, Wakako Yamasawa, Makoto Ishii, Naoki Hasegawa, Tomoko Betsuyaku
Open Journal of Respiratory Diseases
Vol.3 No.2,
May
17,
2013
DOI:
10.4236/ojrd.2013.32006
-
Safety, Tolerability, and Pharmacokinetics of E3030, a Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist, in Healthy Japanese Male Subjects
Yutaka Takeuchi, Yuki Nishioka, Yasumi Kitahara, Setsuo Hasegawa, Akihiro Ohnishi
Pharmacology & Pharmacy
Vol.5 No.2,
February
10,
2014
DOI:
10.4236/pp.2014.52019
-
The Role of Angiotensin II Type 1 Receptor-Activating Antibodies in Vascular Inflammation
Yanxiang Sun, Yong Yuan, Li Feng, Yan Wang
World Journal of Cardiovascular Diseases
Vol.10 No.4,
April
26,
2020
DOI:
10.4236/wjcd.2020.104021
-
Effects of Walnut on Lipid Profile as Well as the Expression of Sterol-Regulatory Element Binding Protein-1c(SREBP-1c) and Peroxisome Proliferator Activated Receptors α (PPARα) in Diabetic Rat
Ebrahim Abbasi Oshaghi, Arash Noori Sorkhani, Ali Rezaei
Food and Nutrition Sciences
Vol.3 No.2,
February
27,
2012
DOI:
10.4236/fns.2012.32037
-
Angiotensin Receptor Type I Blockade Inhibits Apoptosis in Meconium-Instilled Rabbit Lungs
Alexander Zagariya, Shan Navale, Bruce Uhal, Olga Zagariya, Dharmapuri Vidyasagar
Journal of Cancer Therapy
Vol.2 No.5,
December
31,
2011
DOI:
10.4236/jct.2011.25084
-
Intensive Antihypertensive Treatment with Angiotensin Receptor Blocker Combined with Hydrocholorthiazide Reduces Urinary Angiotensinogen in Patients with Type 2 Diabetes Mellitus
Satoru Kuriyama, Naoki Sugano, Kohki Takane, Akimitsu Kobayashi, Yasushi Otsuka, Tatsuo Hosoya
Open Journal of Nephrology
Vol.3 No.2,
June
4,
2013
DOI:
10.4236/ojneph.2013.32015
-
The Significance of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Use in Sudden Cardiac Death
Makoto Onodera, Satoshi Kikuchi, Yasuhisa Fujino, Yoshihiro Inoue, Yuji Fujita
International Journal of Clinical Medicine
Vol.8 No.8,
August
17,
2017
DOI:
10.4236/ijcm.2017.88046
-
Physical Activity Alters Superoxide Dismutase Activity and Intercellular Adhesion Molecule 1 Levels in Diabetes Mellitus Type 2 Patients
Anderson Martins Tavares, Leonardo Matta, Jaslana Hainfellner da Silva, Christiane de Oliveira Bensusan, Carla do Nascimento, Giselle Fernandes Taboada, Rodrigo Soares Fortunato, Luciene de Carvalho Cardoso-Weide
Journal of Biosciences and Medicines
Vol.11 No.7,
July
20,
2023
DOI:
10.4236/jbm.2023.117012
-
Inhibition of renin activity by aliskiren ameliorates diabetic nephropathy in type 1 diabetes mouse model
Yan Zhang, Youli Wang, Yunzi Chen, Dilip K. Deb, Tao Sun, Qun Zhao, Yan Chun Li
Journal of Diabetes Mellitus
Vol.2 No.3,
August
31,
2012
DOI:
10.4236/jdm.2012.23055
-
A Retrospective Analysis of Glucagon-Like Peptide 1 Receptor Agonists in Treating Type 2 Diabetes Mellitus Complicated by Nonalcoholic Fatty Liver Disease
Jiaqian Chen, Hongyan Wu
Journal of Biosciences and Medicines
Vol.12 No.3,
March
8,
2024
DOI:
10.4236/jbm.2024.123002
-
The Role for AVE0991 (MAS-Receptor Angiotensin II (1-7) Agonist) in Reducing Cisplatin-Induced Acute Kidney Injury on C57BL/6 Mice
Chris Mathew
Journal of Biosciences and Medicines
Vol.11 No.1,
January
31,
2023
DOI:
10.4236/jbm.2023.111019
-
Onset Time Profiles for Syncope Associated with α1-Adrenoceptor Blockers in Males: Analysis of a Spontaneous Adverse Drug Event Database
Katsuhiro Ohyama, Masaya Furumoto, Munetoshi Sugiura
Pharmacology & Pharmacy
Vol.9 No.12,
December
14,
2018
DOI:
10.4236/pp.2018.912040
-
Forskolin Modulates the Inhibitory Effect of C-Type Natriuretic Peptide on Hypoxia-Induced Atrial Dynamics and Hypoxia Inducible Factor 1 Alpha Activity
Chengming Guan, Yanan Jia, Chaochao Bian, Bo Zhang, Dazhi Ding, Xun Cui
Journal of Biosciences and Medicines
Vol.5 No.1,
January
3,
2017
DOI:
10.4236/jbm.2017.51001
-
Distribution and Possible Function of Cannabinoid Receptor Subtype 1 in the Human Prostate
Manabu Kamiyama, Mizuya Fukasawa, Yoshio Takihana, Norifumi Sawada, Hiroshi Nakagomi, Mitsuharu Yoshiyama, Isao Araki, Masayuki Takeda
Open Journal of Urology
Vol.3 No.2,
May
17,
2013
DOI:
10.4236/oju.2013.32020
-
Molecular Characterization, 3D Modeling of Grass Carp Interleukin-10 Receptor 1 (IL10R1)
He Wei, Shangnian Wang, Lei Qin, Xinyan Wang, Hong Zhou
Engineering
Vol.5 No.10B,
October
31,
2013
DOI:
10.4236/eng.2013.510B045
-
Role of Sphingosine 1-Phosphate (S1P) Receptor 1 in Experimental Autoimmune Encephalomyelitis —I
Noriyasu Seki, Yasuhiro Maeda, Hirotoshi Kataoka, Kunio Sugahara, Kenji Chiba
Pharmacology & Pharmacy
Vol.4 No.8,
November
26,
2013
DOI:
10.4236/pp.2013.48089
-
Role of Sphingosine 1-Phosphate (S1P) Receptor 1 in Experimental Autoimmune Encephalomyelitis —II
Noriyasu Seki, Hirotoshi Kataoka, Kunio Sugahara, Atsushi Fukunari, Kenji Chiba
Pharmacology & Pharmacy
Vol.4 No.8,
November
26,
2013
DOI:
10.4236/pp.2013.48090